Incisional hernia recurrence through genomic profiling: a pilot study - Top-Institutions - MDSpire

Incisional hernia recurrence through genomic profiling: a pilot study

  • By

  • R. Calaluce

  • J. W. Davis

  • S. L. Bachman

  • M. M. Gubin

  • J. A. Brown

  • J. D. Magee

  • T. S. Loy

  • B. J. Ramshaw

  • U. Atasoy

  • May 31, 2012

  • 0 min

Share

Top Institutions in Surgery

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • General Surgery
    • Genomic Medicine
    • Wound Healing Research

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • General Surgery
    • Genetics
    • Translational Medicine

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Surgical Research
    • Genomic Medicine
    • Regenerative Medicine

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • General Surgery
    • Molecular Genetics
    • Tissue Engineering

  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Surgical Genomics
    • Connective Tissue Research
    • Clinical Genomics

Original Source(s)

Incisional hernia recurrence through genomic profiling: a pilot study

  • by R. Calaluce, J. W. Davis, S. L. Bachman, M. M. Gubin, J. A. Brown, J. D. Magee, T. S. Loy, B. J. Ramshaw, U. Atasoy

  • May 31, 2012

Related Content

Extended validation of the mesh integration (MINT) index: a 1-year porcine study

Comparative outcomes of robotic single-port vNOTES versus robotic-Xi assisted single-incision transumbilical surgery for hysterectomy

FDA Grants Accelerated Approval for OTOF Gene Therapy

A one-time intracochlear gene therapy improved hearing outcomes in patients with OTOF-related sensorineural hearing loss in the phase 1/2 CHORD trial.